TLP
RETA

Tri Locum Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Tri Locum Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-96,274
Closed -$9.82M – 91
2023
Q2 		$9.82M Buy
96,274
+29,068
+43% +$2.96M 3.65% 8
2023
Q1 		$6.11M Sell
67,206
-74,260
-52% -$6.75M 1.86% 20
2022
Q4 		$5.37M Buy
+141,466
New +$5.37M 2.17% 15